Connect with us

CBD News

Cannalysis Receives $22 Million in Funding for Cannabis Testing Expansion

Ella Hughes

Published

on

Cannalysis Cannabis Product Analysis Firm Secures Over $22 Million to Test Vaping Additives
- Ad -

Regulations require that cannabis, hemp and CBD products have to be thoroughly lab tested before they are made available in the market for consumption. There are, however, many black-market products out in the market that have not been adequately tested. Consumers need to understand that there is great risk in consuming cannabinoids that have not been tested by licensed laboratories.

Cannabis-testing labs are currently regulated independently by the state governments hence causing inconsistencies in the quality and standard of cannabis products. CanLab, a CBD, hemp and cannabis testing laboratory network, has come up with a Universalized Ecosystem that will build on trust and transparency in the cannabis testing industry.

Cannalysis Lab, a California-based licensed and ISO/IEC 17025-accredited hemp-testing laboratory in the United States, has received a funding of $22 million from CanLab. With this capital, Cannalysis Lab will be in a position to expand its operations across the country to almost double its current size.

“Hemp and Cannabis testing is still a young industry which presents a lot of opportunities as the utility of CBD continues to become prevalent. The legalization of cannabis has also become widespread, making the marijuana market a safe and secure market with enormous opportunities,” said Gary Hopkinson, CanLab’s Executive Chairman. “Cannalysis has set the bar high in the standards of CBD and hemp testing through the employment of reliable modern technology and automation of the process. We are working together with Cannalysis to help hemp growers and CBD brands pass the ever-strict compliance regulations,” he added.

Through a combination of validated scientific methods, robotics and its proprietary technology, Cannalysis provides testing services that meet the state compliance standards. This has enabled the company to reduce errors and variability hence yielding accurate results. Data automation and robotics have helped reduce human errors. Consumers can also follow the testing process in real-time.

“Cannalysis laboratories feature the most recent technologies for testing CBD, hemp and cannabis. We offer quality beyond compliance through streamlining the process by pushing test results to other third-party platforms and automation of sample preparation,” said Brian Lannon, Cannalysis CEO.

CBD Manufacturers and cannabis growers can follow up testing processes and access the company’s APIs to automate the flow of test results between third-parties integrating them with the internal ERP. Apart from potency testing, Cannalysis goes ahead to test for other substances that may be harmful to consumers, such as microbial, heavy metals and pesticides.

Ella D. Hughes’ input strengthens the legal presence at TOC with her litigator nature and fondness with fitness and adamant cooking skills. During her undergraduate study, she dove deep into diverse fields of psychology, theater, evolutionary biology, psychopharmacology, and romance languages. After being admitted to the bar, TOC is leaning on Ella to help cover the rapidly evolving cannabis and hemp industries for legal insights and regulatory law feedback.

Continue Reading

Ultimate CBD Guide


Disclaimer

ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email contact@timesofcbd.com

Copyright © 2020 TimesofCBD.com | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.